The company had previously halted shipments to certain older patients following the deaths of two teenagers treated with the ...

A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

The anemia treatment missed its main goal in a myelofibrosis study. Meanwhile, Blenrep's return to the U.S. market may have ...

According to multiple reports, a 51-year-old man with limb-girdle muscular dystrophy died from acute liver failure after ...

Overall venture funding, as well as “first financing” rounds, fell significantly in the second quarter, erasing what had been ...